Vasoactive Peptides Flashcards

1
Q

angiotensin II, vasopressin, endothelins, and neuropeptide Y are _________

A

vasoconstrictors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

bradykinins, natriuretic peptides, vasoactive intestinal peptide, substance P, neurotensin, and calcitonin gene related peptide are __________

A

vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_______ cells are the site of synthesis, storage, and release of renin, location of macula densa beside renin secreting JG cells in afferent arteriole

A

granular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • increased NaCl flux through chemoreceptors in macula densa
  • elevated BP through baroreceptors in afferent arteriole wall
  • beta blockade by inhibiting sympathetic stimulation
  • negative feedback by angiotensin II
A

all inhibit renin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

angiotensin will ______ peripheral resistance to increase afterload, ______ aldosterone secretion to increase preload

A

increase

increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACE inhibitors _______ both preload and afterload

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

only active ACE inhibitor?

A

captopril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • reduce angiotensin vasoconstriction with little reflex tachy
  • decrease aldosterone release from adrenal medulla
  • reduce destruction of bradykinin - enhance BP lowering, cause cough and angioedema
  • renal renin secretion may increase b/c of reduction in negative feedback by AngII
A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • adverse:
  • dry, hacking, nonproductive cough
  • angioedema, anaphylaxis
  • hyperkalemia (due to inhibited aldosterone secretion)
  • contraindicated in last 2 trimesters of pregnancy
A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • receptors predominate in vascular smooth muscle and cause the known actions of Ang2
  • selective for AT1
  • may cause hyperkalemia
  • do not affect bradykinin metabolism
  • sartans
A

angiotensin receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • reduction in plasma renin activity

- reduce BP

A

renin inhibitor (aliskiren)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • potent arteriodilators formed by kallikreins

- produce pain, swelling, redness

A

kinins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • synthesized in hypothalamus together with oxytocin, secreted from posterior pituitary
  • produce antidiuretic and vasopressor effects, (V1-vasoconstriction, V2-antidiuresis)
A

vasopressin (ADH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • long acting analog with minimal V1 activity

- promotes antidiuresis, deficiency results in diabetes insipidus

A

desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • drug with both V1a and V2 antagonist effects

- approved for treatment of hyponatremia

A

conivaptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • potent vasoconstrictor substances, locally acting

- ETA smooth muscle vasoconstriction, ETB release of EDRF and prostanoids

A

endothelins

17
Q
  • vasoconstriction - direct inotropy and chronotropy
  • prolonged increase in BP
  • contraction of tracheal and bronchial smooth muscle
  • decreased GFR
  • increased renin
A

endothelin

18
Q
  • nonselective ETA/ETB receptor antagonist
  • approved for pulmonary hypertension, decreases pulmonary vascular resistance
  • adverse: hypotension, increased HR, hepatotoxicity
A

bosENtan

19
Q
  • developed as analgesic

- prevents chemo induced emesis

A

aprepitant